HIV-1 Vif, APOBEC, and intrinsic immunity
- PMID: 18577210
- PMCID: PMC2443170
- DOI: 10.1186/1742-4690-5-51
HIV-1 Vif, APOBEC, and intrinsic immunity
Abstract
Members of the APOBEC family of cellular cytidine deaminases represent a recently identified group of proteins that provide immunity to infection by retroviruses and protect the cell from endogenous mobile retroelements. Yet, HIV-1 is largely immune to the intrinsic antiviral effects of APOBEC proteins because it encodes Vif (viral infectivity factor), an accessory protein that is critical for in vivo replication of HIV-1. In the absence of Vif, APOBEC proteins are encapsidated by budding virus particles and either cause extensive cytidine to uridine editing of negative sense single-stranded DNA during reverse transcription or restrict virus replication through deaminase-independent mechanisms. Thus, the primary function of Vif is to prevent encapsidation of APOBEC proteins into viral particles. This is in part accomplished by the ability of Vif to induce the ubiquitin-dependent degradation of some of the APOBEC proteins. However, Vif is also able to prevent encapsidation of APOBEC3G and APOBEC3F through degradation-independent mechanism(s). The goal of this review is to recapitulate current knowledge of the functional interaction of HIV-1 and its Vif protein with the APOBEC3 subfamily of proteins and to summarize our present understanding of the mechanism of APOBEC3-dependent retrovirus restriction.
Figures



Comment in
-
APOBEC3G encapsidation into HIV-1 virions: which RNA is it?Retrovirology. 2008 Jul 2;5:55. doi: 10.1186/1742-4690-5-55. Retrovirology. 2008. PMID: 18597677 Free PMC article.
Similar articles
-
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.J Mol Biol. 2014 Mar 20;426(6):1220-45. doi: 10.1016/j.jmb.2013.10.033. Epub 2013 Nov 2. J Mol Biol. 2014. PMID: 24189052 Free PMC article. Review.
-
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.J Virol. 2017 Jan 18;91(3):e02230-16. doi: 10.1128/JVI.02230-16. Print 2017 Feb 1. J Virol. 2017. PMID: 27881650 Free PMC article.
-
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.Mini Rev Med Chem. 2008 Mar;8(3):231-8. doi: 10.2174/138955708783744047. Mini Rev Med Chem. 2008. PMID: 18336343 Review.
-
Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061. Epub 2008 Jun 28. J Mol Biol. 2008. PMID: 18619467
-
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Expert Rev Mol Med. 2010 Jan 22;12:e4. doi: 10.1017/S1462399409001343. Expert Rev Mol Med. 2010. PMID: 20096141 Free PMC article. Review.
Cited by
-
Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.J Biol Chem. 2015 Feb 13;290(7):4010-21. doi: 10.1074/jbc.M114.624262. Epub 2014 Dec 25. J Biol Chem. 2015. PMID: 25542899 Free PMC article.
-
The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.Nat Struct Mol Biol. 2012 Oct;19(10):1005-10. doi: 10.1038/nsmb.2378. Epub 2012 Sep 23. Nat Struct Mol Biol. 2012. PMID: 23001005
-
Stably expressed APOBEC3F has negligible antiviral activity.J Virol. 2010 Nov;84(21):11067-75. doi: 10.1128/JVI.01249-10. Epub 2010 Aug 11. J Virol. 2010. PMID: 20702622 Free PMC article.
-
Vpr and Its Cellular Interaction Partners: R We There Yet?Cells. 2019 Oct 24;8(11):1310. doi: 10.3390/cells8111310. Cells. 2019. PMID: 31652959 Free PMC article. Review.
-
Human cellular restriction factors that target HIV-1 replication.BMC Med. 2009 Sep 16;7:48. doi: 10.1186/1741-7015-7-48. BMC Med. 2009. PMID: 19758442 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical